Navigation Links
Study: Carbon monoxide exposure can be reduced during routine anesthesia in kids

Washington, DC Doctors at Children's National Medical Center have found that carbon monoxide levels in the blood of young children increase during routine general anesthesia. Anesthesiologists have found for the first time that, under certain circumstances, infants and children may be exposed to carbon monoxide during routine anesthesia resulting in a rise in the carbon monoxide levels in the child's blood. Because carbon monoxide can be generated as a byproduct of anesthesia, anesthesiologists world-wide use specific precautions to prevent and limit its production, according to Richard J. Levy, MD, Chief of Cardiac Anesthesiology, at Children's National. Dr. Levy's team identified the conditions in which carbon monoxide may be inhaled during anesthesia:

  • The first study demonstrated that carbon monoxide detected in the breathing circuit correlated with the increase in blood levels in children 2 years and older. The study included 15 patients between 4 months and 8 years.
  • The second study identified that the patient's own exhaled carbon monoxide may be "re-breathed" during low-flow anesthesia the current standard of care where fresh gas flows more slowly into the circuit, rather than rapidly.

"The main goal is to provide the safest environment for young patients who require surgery," said Dr. Levy. "We have identified tangible ways to reduce the risk of carbon monoxide exposure, and our hope is that these changes will be implemented internationally."

Much remains unknown about the effects of low-dose carbon monoxide exposure on the developing brain. Several recent studies have suggested there may be a link to hearing impairments. Though there is more research to be done to determine these impacts, Dr. Levy recommends two immediate changes that will eliminate the risk of carbon monoxide exposure in children:

  • In the anesthesia machine, use carbon dioxide absorbents that lack strong metal alkali and do not degrade inhaled anesthetics (avoids CO production risk)
  • Avoid of low-flow anesthesia (avoids CO re-breathing risk)

Following Dr. Levy's study findings, Children's National switched to the recommended absorbent to minimize the risk to patients. Although the sample size is small, the results are compelling and Dr. Levy believes changes should be implemented.

Dr. Levy's research has been named the top study out of 600 at the International Anesthesia Research Society 2010 meeting, and won the John J. Downes Research Award for best abstract at the upcoming Society of Pediatric Anesthesia/American Academy of Pediatrics 2010 Annual meeting.


Contact: Emily Dammeyer
Children's National Medical Center

Related biology news :

1. New study: The kitchen-counter diet
2. U of I study: Lack of omega-3 fatty acid linked to male infertility
3. U of I study: Lack of omega-6 fatty acid linked to severe dermatitis
4. Study: Low levels of vitamin D linked to higher rates of asthma in African-American kids
5. Study: Grass, fungus combination affects ecology
6. Study: Climate change one factor in malaria spread
7. Study: Gene therapy reverses effects of lethal childhood muscle disorder in mice
8. Study: Crickets forewarn unborn babies about spiders
9. New UC Davis study: Climate tipping points may arrive without warning, says top forecaster
10. New study: Human running speeds of 35 to 40 mph may be biologically possible
11. Study: Sea stars bulk up to beat the heat
Post Your Comments:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced broader entry into the automotive market ... that match the pace of consumer electronics human interface ... sensors are ideal for the automotive industry and will ... Europe , Japan ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... SUNNYVALE, Calif. , Nov. 24, 2015 ... executives will be speaking at the following conference, and ... New York, NY      Tuesday, December 1, ... New York, NY      Tuesday, December 1, ...      Piper Jaffray Healthcare Conference, New York, NY ...
Breaking Biology Technology: